Healio

Early ID consult improves outcomes for hospitalized patients

Please provide your email address to receive an email when new articles are posted on . “Previous studies in the United States have been limited to individual centers or infections, or to Medicare ...
Healio

ID consult improves outcomes for patients with gram-negative BSI

Please provide your email address to receive an email when new articles are posted on . Patients with gram-negative BSI who received an infectious disease consultation had a lower risk for 30- and ...
ascopubs.org

Outcomes of invasive ductal (ID) or invasive lobular (IL) early stage breast cancer in women treated with anastrozole or exemestane in the Canadian cancer trials Group MA.27.

A phase II study of the PI3K inhibitor taselisib (GDC-0032) combined with fulvestrant (F) in patients (pts) with HER2-negative (HER2-), hormone receptor-positive (HR+) advanced breast cancer (BC).
ascopubs.org

Identification of multifunctional cytotoxic T-cell subsets as immune correlates with clinical outcomes in a phase II study of AGS-003, an autologous dendritic cell-based ...

Comparison of SearchLight and Luminex multiplex assays: A case study of 27 cytokines in 156 melanoma blood serum samples. This is an ASCO Meeting Abstract from the Markers in Cancer. This abstract ...
Nature

Role of caregiver-reported outcomes in identification of children with prenatal alcohol exposure during the first year of life

Earlier identification of children with prenatal alcohol exposure (PAE) remains a challenge. The objective of this study was to identify neurobehavioral (NB) outcomes associated with PAE in infants.